Precede Biosciences Presents New ESMO 2025 Data Demonstrating Its Liquid Biopsy Platforms Ability to Resolve Target Expression and Molecular Subtypes in Small Cell Lung Cancer
Small cell lung cancer (SCLC) accounts for 15% of all lung cancers…
Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
Announced first patient dosed in the Phase 2b placebo-controlled portion of the…
INFIDIGIT, INDIA’S LEADING SEO COMPANY, CONTINUES TO INNOVATE WITH CLIENT-CENTRIC DEVELOPMENTS THROUGH INFIGROWTH
MUMBAI, India, June 2, 2025 /PRNewswire/ -- Infigrowth, the digital growth platform developed…
